PT  - JOURNAL ARTICLE
AU  - Walaa A. Abualsunun
AU  - Micheline Piquette-Miller
TI  - Involvement of Nuclear Factor <em>κ</em>B, not Pregnane X Receptor, in Inflammation-Mediated Regulation of Hepatic Transporters
AID  - 10.1124/dmd.117.076927
DP  - 2017 Oct 01
TA  - Drug Metabolism and Disposition
PG  - 1077--1083
VI  - 45
IP  - 10
4099  - http://dmd.aspetjournals.org/content/45/10/1077.short
4100  - http://dmd.aspetjournals.org/content/45/10/1077.full
SO  - Drug Metab Dispos2017 Oct 01; 45
AB  - Endotoxin-induced inflammation decreases the hepatic expression of several drug transporters, metabolizing enzymes, and nuclear transcription factors, including pregnane X receptor (PXR). As the nuclear factor κB (NF-κB) is a major mediator of inflammation, and reciprocal repression between NF-κB and PXR signaling has been reported, the objective of this study was to examine whether NF-κB directly regulates the expression of transporters or exerts its effect indirectly via PXR. PXR-deficient (−/−) or wild-type (+/+) male mice were dosed with the selective NF-κB inhibitor PHA408 (40 mg/kg i.p.) or vehicle (n = 5–8/group), followed by endotoxin (5 mg/kg) or saline 30 minutes later. Animals were sacrificed at 6 hours; samples were analyzed using quantitative reverse-transcription polymerase chain reaction and Western blots. Endotoxin induced tumor necrosis factor-α, interleukin (IL)-6, IL-1β, and inducible nitric oxide synthase in PXR (+/+) and (−/−) mice. As compared with saline controls, endotoxin administration imposed 30%–70% significant decreases in the expression of Abcb1a, Abcb11, Abcc2, Abcc3, Abcg2, Slc10a1, Slco2b1, and Slco1a4 in PXR (+/+) and (−/−) mice to a similar extent. Preadministration of PHA408 attenuated endotoxin-mediated changes in both PXR (+/+) and (−/−) mice (P < 0.05). Our findings demonstrate that endotoxin activates NF-κB and imposes a downregulation of numerous ATP-binding cassette and solute carrier transporters through NF-κB in liver and is independent of PXR. Moreover, inhibition of NF-κB attenuates the impact of endotoxin on transporter expression. As NF-κB activation is involved in many acute and chronic disease states, disease-induced changes in transporter function may be an important source of variability in drug response. This information may be useful in predicting potential drug–disease interactions.